Fasenra

AstraZeneca drug fails one main goal in study of chronic immune disease

Read more

US FDA declines to approve AstraZeneca treatment for chronic nasal condition

Read more

AstraZeneca’s Asthma drug Benralizumab gets marketing approval from DCGI

Read more

AstraZeneca Pharma India gets DCGI nod for benralizumab injection, Fasenra

Read more

FASENRA eliminated OCS in a majority of asthma patients in PONENTE Phase IIIb trial

Read more

US FDA grants orphan drug status to AstraZeneca’s asthma drug Fasenra

Read more